About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 321-340 of 675 trials

RecruitingStudy of ORIC-944 in Patients With Metastatic Prostate CancerThe purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic…NCT05413421·Colorado Springs, Colorado and 26 others CompletedStudy of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate CancerThe purpose of this study is to determine whether combination treatment of prostate cancer with IMC-A12 (an antibody which blocks insulin-like growth factor receptor activity)…NCT00769795·Seattle, Washington and 2 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingTesting Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM)This phase II trial examines antiandrogen therapy interruptions in patients with hormone-sensitive prostate cancer that has spread to other places in the body (metastatic)…NCT05241860·Phoenix, Arizona and 325 others

CompletedStudy Using CP-461 to Treat Advanced Prostate CancerThe purpose of this study is to investigate whether an investigational drug, CP-461, is safe and effective for the treatment of patients with prostate cancer and who have…NCT00036075·New York, New York and 1 other

CompletedCabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)The goal of this study is to determine the recommended phase 2 dose of the multi-drug combination of abiraterone, cabozantinib, and nivolumab in conjunction with ongoing androgen…NCT04477512·St Louis, Missouri

TerminatedGenomic Guided Therapy With Dasatinib or Nilutamide in Metastatic Castration-Resistant Prostate CancerThis is a phase II multi-center study to determine the clinical impact of using a patient-specific genomic expression signature of androgen receptor (AR) activity to determine…NCT00918385·Durham, North Carolina and 2 others

RecruitingA First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)This is a first-in-human (FIH), open-label, Phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and preliminary efficacy of ML261, an autologous potency enhanced…NCT07488923·St Louis, Missouri and 6 others

TerminatedEfficacy and Safety of Pembrolizumab (MK-3475) Plus Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (MK-3475-991/KEYNOTE-991)This study will assess the efficacy and safety of pembrolizumab plus enzalutamide plus Androgen Deprivation Therapy (ADT) versus placebo plus enzalutamide plus ADT in participants…NCT04191096·Anchorage, Alaska and 233 others

UnknownUse of Pedometer Following Radical ProstatectomyThis is a study to evaluate whether use of a pedometer following radical prostatectomy decreases post-operative narcotic use and time to return of bowel function.NCT04206280·Seattle, Washington

TerminatedDocetaxel in Combination With GVAX ® Immunotherapy Versus Docetaxel and Prednisone in Prostate Cancer PatientsThe primary objective of this study is to compare the duration of survival between patients receiving docetaxel in combination with the GVAX® vaccine for prostate cancer versus…NCT00133224·Anchorage, Alaska and 114 others

TerminatedSafety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate CancerThe study will consist of 2 parts: Part I (Dose Escalation) and Part II (Dose Expansion).NCT02606123·Scottsdale, Arizona and 4 others

TerminatedA Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsStudy CP-MGC018-03 is an open-label, two-part, Phase 2 study.NCT05551117·Fountain Valley, California and 62 others

CompletedCyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionThe purpose of this study is to determine the effects of CyberKnife radiosurgery in patients with early stage organ-confined prostate cancer.NCT00643994·Phoenix, Arizona and 22 others

CompletedSafety and Tolerability of Atezolizumab (ATZ) in Combination With Radium-223 Dichloride (R-223-D) in Metastatic Castrate-Resistant Prostate Cancer (CRPC) Progressed Following Treatment With an Androgen Pathway InhibitorThis study is designed to assess the safety and tolerability of atezolizumab when given in combination with radium-223 dichloride in participants with metastatic CRPC who have…NCT02814669·Duarte, California and 16 others

CompletedSurvivorship Care Plans and Telehealth Education for the Improvement of Access to Cancer Survivorship, the IMPACT StudyThis trial studies how well self-generated survivorship care plans and telehealth education works in improving knowledge and self-efficacy in cancer survivors living in rural…NCT04081779·Seattle, Washington

TerminatedSafety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPCA phase 1 study evaluating the safety, tolerability, pharmacokinetics, and efficacy of prostate specific membrane antigen half-life extended bispecific T-cell engager acapatamab…NCT03792841·Campbell, California and 29 others

CompletedEffect of Treatment on Work Experience in Patients With Stage I-III Prostate CancerThe objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare…NCT03963739·Phoenix, Arizona and 325 others

TerminatedStudy of KOS-862 (Epothilone D) in Metastatic Prostate CancerThe purpose of this trial is to study KOS-862 in men with metastatic prostate cancer who have failed a docetaxel-containing regimen.NCT00104130·Vallejo, California and 8 others

RecruitingA Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerThe purpose of Parts 1, 2A, and 2B of the study is to determine the recommended regimen for Phase 2 (RP2Rs) of combination of JNJ-87189401 with JNJ-78278343 and the purpose of…NCT06095089·Aurora, Colorado and 19 others

RecruitingA Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesThis is a Phase 1a/1b, open-label, multicenter dose escalation and dose expansion clinical study to evaluate the safety, PK, immunogenicity and preliminary efficacy of IDE034 in…NCT07503808·Denver, Colorado and 14 others

PreviousPage 17 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma